Barbro W van der Burght1, Morten Hansen, Jørgen Olsen, Jilin Zhou, Yalin Wu, Mogens H Nissen, Janet R Sparrow. 1. Department of International Health, Immunology and Microbiology, Eye Research Unit, University of Copenhagen, Copenhagen, DenmarkDepartment of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, DenmarkDepartment of Ophthalmology, Columbia University, New York, New York, USA.
Abstract
PURPOSE: Accumulation of bisretinoids as lipofuscin in retinal pigment epithelial (RPE) cells is implicated in the pathogenesis of some blinding diseases including age-related macular degeneration (AMD). To identify genes whose expression may change under conditions of bisretinoid accumulation, we investigated the differential gene expression in RPE cells that had accumulated the lipofuscin fluorophore A2E and were exposed to blue light (430 nm). METHODS: A2E-laden RPE cells were exposed to blue light (A2E/430 nm) at various time intervals. Cell death was quantified using Dead Red staining, and RNA levels for the entire genome was determined using DNA microarrays (Affymetrix GeneChip Human Genome 2.0 Plus). Array results for selected genes were confirmed by real-time reverse-transcriptase polymerase chain reaction. RESULTS: Principal component analysis revealed that the A2E-laden RPE cells irradiated with blue light were clearly distinguishable from the control samples. We found differential regulation of genes belonging to the following functional groups: transcription factors, stress response, apoptosis and immune response. Among the last mentioned were downregulation of four genes that coded for proteins that have an inhibitory effect on the complement cascade: (complement factor H, complement factor H-related 1, complement factor I and vitronectin) and of two belonging to the classical pathway (complement component 1, s subcomponent and complement component 1, r subcomponent). CONCLUSION: This study demonstrates that blue light irradiation of A2E-laden RPE cells can alter the transcription of genes belonging to different functional pathways including stress response, apoptosis and the immune response. We suggest that these molecules may be associated to the pathogenesis of AMD and can potentially serve as future therapeutic targets.
PURPOSE: Accumulation of bisretinoids as lipofuscin in retinal pigment epithelial (RPE) cells is implicated in the pathogenesis of some blinding diseases including age-related macular degeneration (AMD). To identify genes whose expression may change under conditions of bisretinoid accumulation, we investigated the differential gene expression in RPE cells that had accumulated the lipofuscin fluorophore A2E and were exposed to blue light (430 nm). METHODS:A2E-laden RPE cells were exposed to blue light (A2E/430 nm) at various time intervals. Cell death was quantified using Dead Red staining, and RNA levels for the entire genome was determined using DNA microarrays (Affymetrix GeneChip Human Genome 2.0 Plus). Array results for selected genes were confirmed by real-time reverse-transcriptase polymerase chain reaction. RESULTS: Principal component analysis revealed that the A2E-laden RPE cells irradiated with blue light were clearly distinguishable from the control samples. We found differential regulation of genes belonging to the following functional groups: transcription factors, stress response, apoptosis and immune response. Among the last mentioned were downregulation of four genes that coded for proteins that have an inhibitory effect on the complement cascade: (complement factor H, complement factor H-related 1, complement factor I and vitronectin) and of two belonging to the classical pathway (complement component 1, s subcomponent and complement component 1, r subcomponent). CONCLUSION: This study demonstrates that blue light irradiation of A2E-laden RPE cells can alter the transcription of genes belonging to different functional pathways including stress response, apoptosis and the immune response. We suggest that these molecules may be associated to the pathogenesis of AMD and can potentially serve as future therapeutic targets.
Authors: A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron Journal: Nat Genet Date: 2001-12 Impact factor: 38.330
Authors: So R Kim; Young P Jang; Steffen Jockusch; Nathan E Fishkin; Nicholas J Turro; Janet R Sparrow Journal: Proc Natl Acad Sci U S A Date: 2007-11-28 Impact factor: 11.205
Authors: Mariusz Zareba; Christine M B Skumatz; Tadeusz J Sarna; Janice M Burke Journal: Invest Ophthalmol Vis Sci Date: 2014-07-17 Impact factor: 4.799
Authors: Jin Yang; Yao Li; Lawrence Chan; Yi-Ting Tsai; Wen-Hsuan Wu; Huy V Nguyen; Chun-Wei Hsu; Xiaorong Li; Lewis M Brown; Dieter Egli; Janet R Sparrow; Stephen H Tsang Journal: Hum Mol Genet Date: 2014-02-04 Impact factor: 6.150
Authors: Samuel Bert Boadi-Kusi; Sampson Listowell Abu; George Oppong Acheampong; Peter Osei-Wusu Adueming; Emmanuel Kwasi Abu Journal: J Environ Public Health Date: 2020-04-27
Authors: Patty P A Dhooge; Esmee H Runhart; Catherina H Z Li; Corrie M de Kat Angelino; Carel B Hoyng; Renate G van der Molen; Anneke I den Hollander Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240
Authors: Mark A Gutierrez; Sonnet S Davis; Andrew Rosko; Steven M Nguyen; Kylie P Mitchell; Samiha Mateen; Joana Neves; Thelma Y Garcia; Shaun Mooney; Gary H Perdew; Troy D Hubbard; Deepak A Lamba; Arvind Ramanathan Journal: Sci Rep Date: 2016-07-01 Impact factor: 4.379